Second-generation pterocarpanquinones: synthesis and antileishmanial activity

BACKGROUND: Despite the development of new therapies for leishmaniasis, among the 200 countries or territories reporting to the WHO, 87 were identified as endemic for Tegumentary Leishmaniasis and 75 as endemic for Visceral Leishmaniasis. The identification of antileishmanial drug candidates is esse...

Descripción completa

Detalles Bibliográficos
Autores principales: Faiões, Viviane dos Santos, da Frota, Lívia C. R. M., Cunha-Junior, Edézio Ferreira, Barcellos, Julio C. F., Da Silva, Thayssa, Netto, Chaquip Daher, Da-Silva, Silvia Amaral Gonçalves, da Silva, Alcides J. M., Costa, Paulo R. R., Torres-Santos, Eduardo Caio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263544/
https://www.ncbi.nlm.nih.gov/pubmed/30519257
http://dx.doi.org/10.1186/s40409-018-0174-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263544/
https://www.ncbi.nlm.nih.gov/pubmed/30519257
http://dx.doi.org/10.1186/s40409-018-0174-7

Ejemplares similares